Intel Corp. is a Strong Buy with a $66.62 price target, despite near-term supply constraints and negative Q4'25 sentiment.

PAAS is a BUY based on continued U.S. dollar weakness and a flight to quality given the massive global trade and national security uncertainties. Click to read.

A psychedelic compound found in “magic mushrooms” could help Australians with binge-eating disorders control the urge for ...

Hyperliquid’s rapid rise poses a test for decentralization.

Great Southern Bancorp, Inc. (the “Company”) (NASDAQ:GSBC), the holding company for Great Southern Bank (the “Bank”), today reported that preliminary earnings for the three months ended December 31, ...

A 2025 crypto year in review on institutions, AI-driven markets, macro forces, and why the four-year cycle may be over.

Background Aortic stenosis (AS) frequently coexists with heart failure (HF), but its prevalence, prognostic impact and management across the full HF spectrum remain incompletely characterised. Methods ...

From Bill Demchak, PNC Chairman and Chief Executive Officer: "By virtually all measures, 2025 was a successful year. Strong execution across all business lines resulted in record ...

Background Up to half of patients with infective endocarditis (IE) require cardiac surgery. Although anaemia is common, its ...

Background Autoimmune neutropenia (AIN) is the main cause of chronic neutropenia in children, but its infectious consequences ...

Amerant Bancorp Inc. (NYSE: AMTB) (the "Company" or "Amerant") today reported net income attributable to the Company of $2.7 million in the fourth quarter of 2025, or $0.07 per diluted share, compared ...

Objective To help to clarify whether long term use of proton pump inhibitors is associated with an increased risk of gastric adenocarcinoma by designing a study that considered the existing literature ...